| ONCOS-102 | |
|---|---|
Virus classification 
| |
| (unranked): | Virus |
| Realm: | Varidnaviria |
| Kingdom: | Bamfordvirae |
| Phylum: | Preplasmiviricota |
| Class: | Tectiliviricetes |
| Order: | Rowavirales |
| Family: | Adenoviridae |
| Genus: | Mastadenovirus |
| Species: | Human mastadenovirus C
|
ONCOS-102 (Ad5/3-D24-GMCSF),[1] (developed by Oncos Therapeutics) is an oncolytic adenovirus previously described as CGTG-102.[2] It is currently in orphan drug status for soft tissue sarcomas.[citation needed]
- ^ "Oncos.net". Archived from the original on 2013-04-13. Retrieved 2016-03-14.
- ^ "Notification report". gmoinfo.jrc.ec.europa.eu. European Commission - Joint Research Centre. 2016-02-03. Retrieved 2021-03-27.